Company Profile
Genen Pharmaceuticals Co.,Ltd, a subsidiary of Genen International Group, whose business covers pharmaceuticals and new energy, is a specialized manufacturer and supplier of advanced and key pharmaceutical intermediates and relevant API. With own standard lab, pilot plant and industrialization base, we made plenty of investment into R&D. Our core R&D team is made up of quite a few of doctors and engineers with great pharmaceutical background and rich experiences, which ensures the company to provide the customers with high quality products and servces. With advanced production process, we implement strict QC procedure and conduct inspection to all the product strictly according to regulations under related pharmacopoeia and ICH to make sure that the quality meets the customers' requirements. Our main products, including bortezomib, bortezomib intermediates, elinogreil, paclitaxel, crizotinib and other API, are widely used in reagen production and research fields like cell pharmaceutical theory and molecular biology. Beisides, we also supply a range of domestically made API, most of which are from GMP certified manufacturers and some have already been certified by FDA. We would like to make cutomised products and achieve a win-win result with customers.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Benzamide,3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,4-dimethyl-;3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,4-dimethylbenzamide;3-Bromo-4-[(2,4-difluorobenzyl)oxy]-1-[5-[(methylamino)carbonyl]-2-methylphenyl]-6-methylpyridin-2(1H)-one;PH 797804;1073667-47-6 |
586379-66-0 | Inquiry | ||
1-Pentanone, 2-amino-4-methyl-1-[(2R)-2-methyloxiranyl]-, (2S)-,trifluoroacetate |
1-Pentanone, 2-aMino-4-Methyl-1-[(2R)-2-Methyloxiranyl]-, (2S)-, trifluoroacetate (9CI);(S)-2-aMino-4-Methyl-1-((R)-2-Methyloxiran-2-yl)pentan-1-one, trifluoroacetate;(2S)-2-AMino-4-Methyl-1-[(2R)-2-Methyloxiranyl]-1-pentanone trifluoroacetate;(S)-2-amino-4-methyl-1-((R)-2-methyloxiran-2-yl)pentan-1-one trifuoro acid salt;(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanonetrifluoroacetat;(S)-2-Amino-4-methyl-1-((R)-2-methyloxiran-2-yl)pentan-1-one 2,2,2-trifluoroacetate;1-Pentanone, 2-aMino-4-Methyl-1-[(2R)-2-Methyloxiranyl]-, (2S)-, trifluoroacetate;1-Pentanone, 2-amino-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-, (2S)-, 2,2,2-trifluoroacetate (1:1) |
247068-85-5 | - / >99% | Inquiry |
1-Pyrrolidinecarboxylicacid, 2-borono-, 1-(1,1-dimethylethyl) ester |
1-Pyrrolidinecarboxylic acid,2-borono-,1-(1,1-dimethylethyl) ester;1-(1,1-Dimethylethyl) 2-borono-1-pyrrolidinecarboxylate;[1-(tert-Butoxycarbonyl)pyrrolidin-2-yl]boronic acid;NT 0187;[1-[(2-Methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]boronic acid;1-N-Boc-Pyrrolidin-2-ylboronic acid;147228-19-1 |
149682-75-7 | Inquiry | |
2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]- |
2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine;[3-[[(R)-1-(2,6-Dichloro-3-fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine;PF 2341066;PF 02341066;Crizotinib;(R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-ylamine;Xalkori;3-((R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine;912279-98-2 |
877399-52-5 | Inquiry | |
4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile |
[1,1′-Biphenyl]-2-carbonitrile,4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-;1,3-Diazaspiro[4.4]nonane,[1,1′-biphenyl]-2-carbonitrile deriv.;4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1′-biphenyl]-2-carbonitrile;2-Butyl-3-[[2′-(cyano)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;2-[4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]phenyl]benzonitrile;1246929-71-4 |
138401-24-8 | Inquiry | |
4(3H)-Quinazolinone,3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]- |
4(3H)-Quinazolinone,3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-;Febrifugine;3-[3-[(2R,3S)-3-Hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone;β-Dichroine;Dichroin B;β-Dichroin;(+)-Febrifugine;NSC 315535;trans-(+)-Febrifugine;486-68-0;732982-92-2;880384-80-5 |
24159-07-7 | - / >99% | Inquiry |
5-Chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-2-thiophenesulfonamide |
2-Thiophenesulfonamide,5-chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-;5-Chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-2-thiophenesulfonamide;PRT 060128;Elinogrel;N-[4-(6-Fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)phenyl]-N′-[(5-chlorothiophen-2-yl)sulfonyl]urea;1-(5-Chlorothiophen-2-yl)sulfonyl-3-[4-[6-fluoro-7-(methylamino)-2,4-dioxo-1H-quinazolin-3-yl]phenyl]urea |
936500-94-6 | Inquiry | |
Atorvastatin Calcium |
1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),(βR,δR)-;1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),[R-(R*,R*)]-;CI 981;Atorvastatin calcium;YM 548;Lipitor;Atorvastatin hemicalcium;Tahor;Sortis;Atorvastatin hemicalcium salt;Storvas;Rotacor;Atocor;Atoraz;Lowlip;Lorvast;334757-04-9;1108202-55-6;1370463-14-1 |
134523-03-8 | Inquiry | |
Bendamustine hydrochloride |
1H-Benzimidazole-2-butanoic acid,5-[bis(2-chloroethyl)amino]-1-methyl-,hydrochloride (1:1);2-Benzimidazolebutyric acid,5-[bis(2-chloroethyl)amino]-1-methyl-,monohydrochloride;1H-Benzimidazole-2-butanoic acid,5-[bis(2-chloroethyl)amino]-1-methyl-,monohydrochloride;IMET 3393;Cytostasan;ZIMET 33/93;Bendamustin hydrochloride;Bendamustine hydrochloride;Ribomustin;SDX 105;Treanda;Bendit;Purplz |
3543-75-7 | Inquiry | |
Benzamide,4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)- |
Benzamide,4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-;4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide;(R)-4-[(8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide;BI 2536;BI 2356;BI2536 |
755038-02-9 | Inquiry | |
Bortezomib |
Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Boronic acid,[3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-,[S-(R*,S*)]-;Boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;PS 341;PS 341 (pharmaceutical);MG 341;LDP 341;Bortezomib;MLN 341;Velcade;NSC 681239;DPBA;Radiciol;PS 314;Brotezamide;197730-97-5 |
179324-69-7 | Inquiry | |
Calcium folinatc |
L-Glutamic acid,N-[4-[[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-,calcium salt (1:1);Glutamic acid,N-[p-[[(2-amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-,calcium salt (1:1),L-;Calcium L-folinate;Calcium leucovorin;Calcium folinate;Calcium 5-formyltetrahydrofolate;Lederfoline;Leucovorin calcium;Leucovorin calcium salt;Folinic acid calcium salt;Rescuvolin;NSC 3590;Wellcovorin;Folidan;Folinate-SF calcium;6035-86-5;6209-45-6;30771-29-0;1236362-90-5 |
1492-18-8 | Inquiry | |
Carfilzomib |
Carfilzomib;N-{(2S)-2-[(Morpholin-4-ylacetyl)aMino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-Methyl-1-[(2R)-2-Methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninaMide;CarfilzoMib salt;CarfilzoMib/PR 171;PR-171 (CarfilzoMib);(alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide;CarfilzoMib, Free Base, >99%;(S)-4-Methyl-N-((S)-1-((S)-4-Methyl-1-((R)-2- Methyloxiran-2-yl)-1 -oxopentan-2-ylaMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide |
868540-17-4 | - / >99.5% | Inquiry |
CEP 18770 |
Boronic acid,B-[(1R)-1-[[(2S,3R)-3-hydroxy-1-oxo-2-[[(6-phenyl-2-pyridinyl)carbonyl]amino]butyl]amino]-3-methylbutyl]-;Boronic acid,[(1R)-1-[[(2S,3R)-3-hydroxy-1-oxo-2-[[(6-phenyl-2-pyridinyl)carbonyl]amino]butyl]amino]-3-methylbutyl]-;B-[(1R)-1-[[(2S,3R)-3-Hydroxy-1-oxo-2-[[(6-phenyl-2-pyridinyl)carbonyl]amino]butyl]amino]-3-methylbutyl]boronic acid;[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid;CEP 18770;NPH 007098;CT 47098;CIP 18770;Delanzomib |
847499-27-8 | - / >99% | Inquiry |
Dabrafenib Mesylate(GSK-2118436B) |
Benzenesulfonamide,N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-,methanesulfonate (1:1);Dabrafenib mesylate;GSK 2118436 methanesulfonate salt;GSK 2118436B;N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid |
1195768-06-9 | - / >99% | Inquiry |
Dutasteride |
1H-Indeno[5,4-f]quinoline-7-carboxamide,N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-,(4aR,4bS,6aS,7S,9aS,9bS,11aR)-;4-Azaandrost-1-ene-17-carboxamide,N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-,(5α,17β)-;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide;GG 745;Dutasteride;GI 198745;Avodart;Veltride;Avolve;(5α,17β)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide |
164656-23-9 | Inquiry | |
entecavir |
6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-;6H-Purin-6-one,2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,[1S-(1α,3α,4β)]-;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;BMS 200475;Entecavir;SQ 34676;Baraclude;ETV;31: PN: WO2016077321 SEQID: 31 claimed sequence |
142217-69-4 | Inquiry | |
Erlotinib |
4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine;OSI 744;Erlotinib;NSC 718781;R 1415;4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline |
183321-74-6 | Inquiry | |
finasteride |
1H-Indeno[5,4-f]quinoline-7-carboxamide,N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-,(4aR,4bS,6aS,7S,9aS,9bS,11aR)-;4-Azaandrost-1-ene-17-carboxamide,N-(1,1-dimethylethyl)-3-oxo-,(5α,17β)-;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide;MK 906;Finasteride;Proscar;Prostide;Propecia;Finpecia;Finastid;Chibro-Proscar;Fincar;Fistide;Finax;Finast;Finara;Prosteride;N-(tert-Butyl)-3-oxo-4-aza-5α-androst-1-ene-17-carboxamide;Finalo;Geffina;Appecia;Finasterid Alternova |
98319-26-7 | Inquiry | |
gabapentin hydrochloride |
Cyclohexaneacetic acid,1-(aminomethyl)-;1-(Aminomethyl)cyclohexaneacetic acid;Gabapentin;CI 945;Go 3450;GOE 2450;Neurontin;GOE 3450;Gabapen;Bexal;Gabamox;Generis;2-[1-(Aminomethyl)cyclohexyl]acetic acid;Conventin;Neuronyin;Neuril;Convalis;Gabarone;Gralise;Nupentin;Fanatrex;Sigma G 154;(1-Aminomethyl-cyclohexyl)-acetic acid |
60142-96-3 | Inquiry |
CONTACT INFORMATION
Sign In for Details